Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.0 to v3.6.3, representing an update to the page's versioning metadata rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-06-30T10:22:20.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Enrollment status now shows 'No longer looking for participants,' indicating that recruitment for this study has ended. The page also adds new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the revision label to v3.6.0, while removing the older 'Intervention / Treatment' header variant.
    Difference
    0.4%
    Check dated 2026-06-16T01:22:53.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5 on the page, signaling a minor version update rather than changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-09T02:38:45.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page footer shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a small update to the page's versioning/documentation rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-18T13:38:15.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.3, indicating a minor platform/site release without altering the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-27T07:59:43.000Z thumbnail image
  8. Check
    120 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page were observed.
    Difference
    0.1%
    Check dated 2026-03-22T11:32:05.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.